Latest Reports

Market Scope’s "2026 United States Cataract Surgeon Survey Report" provides an in-depth look at the current state and future direction of the US cataract surgery market. Based on responses from 115 cataract surgeons representing more than 1,000 practitioners across a wide range of practice settings, the report delivers actionable insights into surgeon preferences, technology adoption, and evolving market dynamics.

The survey examines practice characteristics, surgical techniques, product utilization, patient education and marketing strategies, and purchasing behavior. Expanded coverage explores premium cataract surgery trends, including presbyopia-correcting, toric, enhanced monofocal, and EDOF IOL adoption, astigmatism management, femtosecond laser-assisted cataract surgery (FLACS), surgical site trends, patient financing, and interest in emerging technologies and equipment.

The report also provides detailed market share analysis by manufacturer, brand, and product category, offering a clear view of the competitive landscape across IOLs, phaco systems, viscoelastics, intraoperative pharmaceuticals, MIGS devices, and other key cataract surgery products. Additional sections examine glaucoma co-management patterns, MIGS utilization, and surgeon perspectives on future market developments.

Designed for manufacturers, investors, and industry stakeholders, this report combines surgeon-reported data with expert analysis to deliver a comprehensive view of the trends shaping the US cataract market, making it an essential resource for strategic planning, product development, and competitive intelligence.

The “2026 Retinal Device Market Report” provides a comprehensive, data-driven analysis of the global retinal device market, including market size, growth trends, and the key developments shaping future demand for major product segments such as vitrectomy machines, vitrectomy packs, accessories and allied surgical products, tamponades, retinal medical devices, maintenance and upgrade revenue, and other surgical devices. It also evaluates the current competitive landscape and provides detailed forecasts through 2031, offering clear insight into how the market is expected to evolve over the next five years. 

In addition, the report profiles 19 leading retinal device companies, with in-depth coverage of their product portfolios, strategic positioning, company background, and outlook to provide a clear view of the competitive dynamics driving the market forward. 

The “2026 European Five Ophthalmic Market Report” delivers a comprehensive, data-driven view of Western Europe’s five largest ophthalmic markets—France, Germany, Italy, Spain, and the United Kingdom—across 11 key submarkets. The report analyzes current market dynamics, identifies the trends shaping demand, and provides clear forecasts through 2031 to support strategic planning and competitive positioning. 

In addition, the report includes detailed disease prevalence forecasts, treatment and procedure volume analysis, emerging technology assessment, and in-depth profiles of leading competitors to provide a complete picture of how these major European markets are evolving and where the strongest opportunities are expected to emerge. 

The "2026 United States Optometry Trends Survey Report" delivers a data-driven view of how optometry practices are structured and evolving—highlighting key trends in clinical care, technology adoption, referral patterns, and growth dynamics. 

Built on extensive primary research and featuring expert commentary from Market Scope, this report explores brand decision drivers and service offerings across medical eye care, contact lenses, dry eye, and myopia management.  

The report also connects optometry to the broader ophthalmic ecosystem, offering unique insight into co-management patterns, cataract and refractive referral behavior, and the factors that drive surgeon selection and premium IOL conversion.  

The “2026 Glaucoma Pharmaceuticals Market Report” provides a data-driven view of the global and regional glaucoma drug markets, highlighting the trends and competitive forces shaping future growth. The report includes forecasts through 2031 across all major therapy classes, including prostaglandins (branded and generic), beta blockers, carbonic anhydrase inhibitors, alpha agonists, fixed combinations, NO-donating compounds, and Rho-kinase inhibitors. 

In addition, the report examines a robust development pipeline of over 30 drug candidates and profiles 23 leading companies, providing insight into product portfolios, strategic positioning, and future outlook. 

The "2025 India Ophthalmic Market Report" delivers a comprehensive analysis of India’s ophthalmic market, highlighting key trends, competitive dynamics, and factors shaping future growth. The report includes forecasts for disease prevalence, procedure volumes, and technology adoption across diagnostic equipment, lasers, cataract, refractive, cornea, glaucoma, retina, dry eye, surgical instruments, and single-use surgical devices. 

Profiles of 30 leading competitors provide insight into product portfolios, strategic positioning, and market outlook. 

Market Scope’s "2025 Corneal Disease Model" delivers detailed, country-level insight into corneal disease prevalence worldwide, with age-specific estimates and five-year forecasts across nine corneal indications for every country with a population over one million.

Built on the latest clinical literature and global demographic projections, this proprietary model provides a consistent, forward-looking view of corneal disease prevalence. The model can be customized by geography and disease category to support strategic planning, including market sizing, evaluation of target populations for clinical- and commercial-stage products, and analysis of how corneal disease demographics are expected to evolve over time.

Market Scope’s “2025 Ophthalmic Diagnostic Equipment Survey Report” provides a data-driven snapshot of how United States ophthalmologists and optometrists are evaluating, purchasing, and using diagnostic technologies in today’s evolving clinical environment.  

Based on a nationwide online survey of 480 verified providers, the report delivers direct insight into capital investment priorities, technology adoption, and the growing influence of digital tools, AI, and data integration across ophthalmic practices.  

This survey report examines how and why purchasing decisions are made, what features and services matter most, how diagnostic budgets are changing, and where practices see value in next-generation technologies. Coverage spans core diagnostic categories as well as fast-growing areas such as artificial intelligence, interoperability, digital applications, and telehealth—offering both a current-state assessment and a forward-looking view of the diagnostic landscape. 

Survey questions were developed by Market Scope in collaboration with sponsoring companies, ensuring the data addresses the most commercially and strategically relevant issues facing diagnostic equipment manufacturers.  

The “2025 Cataract Pharmaceuticals Market Report” provides a comprehensive, data-driven market analysis of the drugs used before, during, and after cataract surgery in the United States and Western Europe. The report examines current utilization patterns and provides five-year forecasts for revenue by product category. 

Coverage includes antibiotics, anti-inflammatory agents, mydriatics/cycloplegics, pain management drugs, and intracameral formulations, along with a detailed look at fixed combinations, branded products, generics, and compounded alternatives. The report also explores evolving surgical practices, the growing role of intracameral injections, reimbursement dynamics, and the competitive pipeline shaping the future of cataract pharmaceuticals.  

The “2025 Dry Eye Pharmaceuticals Market Report” provides a comprehensive analysis of the global market for dry eye therapeutics, examining the disease’s prevalence, diagnosis, and treatment landscape. The report provides in-depth coverage of artificial tears, anti-inflammatory drops, miticides, tear evaporation inhibitors, mucin secretagogues, and other prescription and over-the-counter products—with detailed forecasts of unit demand, sales revenue, and market performance by region through 2030. 

The report offers a data-driven assessment of the current dry eye marketplace and its growth potential, highlighting new product development, emerging drug-delivery methods, and the expanding pharmaceutical pipeline. Global and regional forecasts are presented for seven major regions, with coverage of competitive dynamics, regulatory differences, and therapeutic trends. Profiles are provided for 23 leading companies and their strategic positioning within the dry eye market.